Study Finds Evidence of ‘Reverse Spin Bias’ in Medical Cannabis Research
A previously unrecognised form of reporting bias may be skewing how research on medical cannabis is presented.
24 results for “bias”
A previously unrecognised form of reporting bias may be skewing how research on medical cannabis is presented.
An estimated 10 million people currently suffer from phobia related anxiety in the UK.
ADHD is one of the most commonly reported reasons people seek medical cannabis, but does the evidence support it?
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
A comprehensive guide on how to read and interpret cannabis research.
A new review highlights significant gaps in the evidence for medical cannabis, but other researchers say it may not present a balanced picture.
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
Is regulators’ focus on randomised controlled trials holding back progress in medical cannabis research?
A study of over 4 million adults has revealed that cannabis use may nearly quadruple the risk of developing diabetes.
Current methods used by police to detect drug driving are not based on science, say the authors of a new paper calling for an overhaul of cannabis impairment testing.
The authors of a new Canadian study have called for increased public funding to protect the ‘scientific integrity’ of cannabis research and reduce reliance on industry sponsorship. Research led by […]
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes […]
Researchers analysed data from 4,744 US adults aged 45 and older.
Many people are swapping over the counter and prescription sleep medications for cannabis.
A new report from a UK cannabis advisory company has highlighted how a failure to capture data related to race – when policing illicit adult cannabis use across Europe – […]
Researchers identified ‘statistically significant’ improvements in symptoms, quality of life and a reduction in opioid use.
How the female-led brand is tackling the huge unmet need in women’s healthcare through research and development.
Following a ‘positive’ inaugural meeting, concerns remain over the appointment of the Advisory Support Group.
Only a tiny fraction of UK medical cannabis patients are accessing the legal market. Why is that and what do we do about it?
Women, particularly women of colour, are woefully underrepresented in leadership positions across industries—cannabis can do better, and benefit.
Three new studies from the US and Canada explore different angles to the complex relationship between cannabis use and pregnancy.
Cannabis must be treated the same as any other medication if we want to see mainstream prescribing in the UK, say doctors.
Researchers say THC potency is not necessarily indicative of better quality, or a more positive experience.
New science questions the thinking that cannabis consumption may be a risk factor for post-transplant complications.